NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29 | $7 | -$16 | -$5 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$4 | $2 | $0 | $2 |
| Other Non-Cash | $25 | -$14 | $9 | -$1 |
| Operating Cash Flow | -$7 | -$4 | -$6 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | -$0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | $3 | $6 | $1 |
| Stock Issued | -$0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $18 | $1 | -$0 | $3 |
| Financing Cash Flow | $7 | $4 | $6 | $4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | -$0 | $0 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $2 | $0 | $0 | $0 |
| Free Cash Flow | -$7 | -$4 | -$6 | -$4 |